Patents by Inventor Arne Vernon Astrup

Arne Vernon Astrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PREDICTING AND PROMOTING WEIGHT LOSS IN PATIENTS WITH LOW AMY1 COPY NUMBERS
    Publication number: 20220307064
    Abstract: The invention provides methods for identifying biomarkers in a patient's microbiota to predict a patient's response to a predetermined diet to promote weight loss and methods of promoting weight loss or treating obesity in the patient by optimizing the patient's diet in accordance with the biomarkers identified in the patient's gut microbiota. The methods of the invention can also be used to manage or maintain weight, i.e., prevent or inhibit weight gain, in a patient who is of normal weight or is overweight or obese.
    Type: Application
    Filed: February 3, 2022
    Publication date: September 29, 2022
    Inventors: Mads Fiil Hjorth, Arne Vernon Astrup
  • COMPOSITIONS AND METHODS FOR PREDICTING AND PROMOTING WEIGHT LOSS
    Publication number: 20190062811
    Abstract: The invention provides methods for identifying biomarkers in a patient's microbiota to predict a patient's response to a predetermined diet to promote weight loss and methods of promoting weight loss in the patient by optimizing the patient's diet in accordance with the biomarkers identified in the patient's gut microbiota. The methods of the invention can also be used to manage or maintain weight, i.e., prevent or inhibit weight gain, in a patient who is of normal weight or is overweight or obese.
    Type: Application
    Filed: May 30, 2018
    Publication date: February 28, 2019
    Inventors: Mads Fiil Hjorth, Arne Vernon Astrup, Yishai Zohar
  • Flaxseeds for body weight management
    Patent number: 8877267
    Abstract: The present invention relates to methods for reducing fat uptake in the gastrointestinal tract of a mammal in order to prevent a positive energy balance, weight gain, overweight and obesity, and to induce a negative energy balance and weight loss in subjects who wish to reduce their body weight. In particular, food and/or beverage ingredients and dietary supplements of the present invention comprises flaxseeds useful for increasing faeca fat excretion from the gastrointestinal tract.
    Type: Grant
    Filed: May 10, 2005
    Date of Patent: November 4, 2014
    Assignee: University of Copenhagen
    Inventors: Arne Vernon Astrup, Inge Tetens, Agnete Dal Thomsen
  • Use of GLP-1 Peptides
    Publication number: 20110028391
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 3, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Composition for weight reduction comprising capsaicin, green tea extract, L-tyrosine and caffeine
    Patent number: 7867526
    Abstract: A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: January 11, 2011
    Assignee: Ideasphere, Inc.
    Inventors: Arne Vernon Astrup, Soren Toubro
  • METHOD FOR PREDICTION OF LIPOPROTEIN CONTENT FROM NMR DATA
    Publication number: 20110004453
    Abstract: The invention concerns a method of preparing regression coefficients in a multivariate analysis for predicting the quantity of a component of a lipoprotein entity in a biological sample from NMR spectral data and a method of predicting the quantity of a component of a lipoprotein entity in a biological sample from NMR spectral data, which is based on the regression coefficients. The invention is especially useful for predicting the triacylglycerol level in chylomicrons of a patient.
    Type: Application
    Filed: June 24, 2010
    Publication date: January 6, 2011
    Applicant: Københavns Universitet
    Inventors: Søren Balling ENGELSEN, Francesco Savorani, Flemming Larsen, Mette Kristensen, Arne Vernon Astrup
  • Use of GLP-1 Peptides
    Publication number: 20100113363
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: January 4, 2010
    Publication date: May 6, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Use of GLP-1 Peptides
    Publication number: 20090149387
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: February 12, 2009
    Publication date: June 11, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Use of GLP-1 peptides
    Publication number: 20030232754
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: March 6, 2003
    Publication date: December 18, 2003
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff